A new non-hormonal birth control device for women
Official title: Development of a novel, non-hormonal female contraceptive device to submit IDE
Funded at Venova Technologies, INC. · NIH-11183494 · Data updated 2026-11-12
This project is creating a new long-lasting, non-hormonal birth control device for women that aims to be free of side effects.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Venova Technologies, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | September 21, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $1,125,480 |
| NIH project number | 2R44HD111106-02 |
| Project ID | NIH-11183494 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for future studies would be women seeking a new non-hormonal, long-acting birth control method without the side effects of current options.
✕Less likely to help
Patients who are satisfied with their current hormonal or non-hormonal birth control methods may not seek this alternative.
What this research studies
Many women are looking for birth control options that don't use hormones and don't have bothersome side effects. This project is developing a new device that works without hormones, offering a different choice from current methods. The goal is to create a long-acting contraceptive that avoids common issues like irregular bleeding or pain often linked to existing non-hormonal options. This work is in an advanced development stage, preparing for future testing in primates and eventually in people.
Why it matters
Potential benefit: If successful, this device could offer women a highly effective, long-lasting, and side-effect-free non-hormonal birth control option.
How similar studies have gone: While existing non-hormonal methods have limitations, this approach aims to be novel by combining high effectiveness with a lack of side effects, a gap not fully met by current options.
Where this research is happening
-
Venova Technologies, INC.
Cambridge, United States Active
Researchers
- Principal investigator: Man, Emily — Venova Technologies, INC.
- Study coordinator: Man, Emily
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
HIV in Women: How the virus hides and the immune system changes across life stages
This project looks at how HIV behaves differently in people from puberty through menopause, focusing on how hormones like estrogen may affect HIV persistence and immune responses.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Computational modeling of female hormone balance and drug responses
A new computational model uses patient-like data to predict how metabolic drugs will work in women across their hormonal cycles and different reproductive stages.
-
How PrEP Drugs Affect HIV Risk in Women and Reproductive Health
This project looks at how PrEP medicines work for women, and whether they influence pregnancy-related processes in the uterus.
-
How female eggs throw away most chromosomes during meiosis
A scientist at UC Davis is studying why only a quarter of chromosomes go into the egg during female reproductive cell division and how errors in this process can cause miscarriage or birth defects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.